Nav: Home

Cancer research symposium features internationally recognized experts

November 02, 2016

MINNEAPOLIS (Nov. 2, 2016) - The Masonic Cancer Center, University of Minnesota is hosting its 7th Annual Cancer Research Symposium today and tomorrow, Nov. 2-3, at TCF Bank Stadium. With the goal of celebrating 25 years of research innovation, discovery, and collaborations, the 2-day event will feature internationally recognized cancer researchers and doctors, many of who currently work or have trained at the Masonic Cancer Center, as well as current trainee presenters that represent the vision of tomorrow.

Together, these researchers and trainees will share the work they've explored in many areas of cancer research that have changed lives and move us in new directions.

"We're extremely excited to welcome back such esteemed cancer research experts to Minneapolis," said Dr. Douglas Yee, M.D., director of the Masonic Cancer Center. "Their trainee experience here at the Masonic Cancer Center--and the profound research they have led across the country--is invaluable and has made the fight to end cancer more attainable. We hope this motivational event will spur new ideas and collaborations toward developing new research."

Dr. Yee will deliver the opening remarks on Nov. 2, followed by a keynote address by one of the National Cancer Institute's Outstanding Investigators, Thomas Kensler, Ph.D., professor of Pharmacology and Chemical Biology at University of Pittsburgh's School of Medicine and Johns Hopkins Bloomberg School of Public Health.

Focal points of the symposium include presentations given by Masonic Cancer Center alumni who now work as investigators all over the United States. Topics that will be covered include everything from exercise rehabilitation after breast cancer, to the science of surviving cancer--lessons learned from cancer survivors, to taking apart the complex interactions that influence the evolution of cancer genomes.

Collaborations will be highlighted through engaging presentations, as well as on-site poster sessions that feature graduate students and postdoctoral research trainees sharing their most current cancer research findings.

"The Masonic Cancer Center, University of Minnesota is proud to bring together a scientifically diverse group of cancer researchers in an environment where they can foster new collaborations and generate new, innovative, and novel ideas," said Dr. Yee. "This event will also allow our graduate students and postdoctoral research trainees an opportunity to see what researchers around the United States are working on, and the types of studies and clinical trials they build on as they work to advance their own research careers."
-end-
For more information on the 7th Annual Cancer Research Symposium, including a complete list of sponsors and speakers, please visit the symposium event page.

Masonic Cancer Center, University of Minnesota is a Comprehensive Cancer Center designated by the National Cancer Institute. For more than 25 years, researchers, educators, and care providers have worked to discover the causes, prevention, detection, and treatment of cancer and cancer-related disease. Learn more about the Masonic Cancer Center at cancer.umn.edu.

University of Minnesota - Masonic Cancer Center

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...